104 related articles for article (PubMed ID: 26070653)
1. Variation in the miRNA-433 binding site of FGF20 is a risk factor for Parkinson's disease in Iranian population.
Haghnejad L; Emamalizadeh B; Jamshidi J; Bidoki AZ; Ghaedi H; Ahmadi E; Abdollahi S; Shahmohammadibeni N; Taghavi S; Fazeli A; Motallebi M; Zarneh AE; Mohammadihosseinabad S; Abbaszadegan MR; Torkamandi S; Gavenaroudi MA; Pedram N; Shahidi GA; Tafakhori A; Darvish H; Movafagh A
J Neurol Sci; 2015 Aug; 355(1-2):72-4. PubMed ID: 26070653
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 20 (FGF20) polymorphism is a risk factor for Parkinson's disease in Chinese population.
Pan J; Li H; Wang Y; Ma JF; Zhang J; Wang G; Liu J; Wang XJ; Xiao Q; Chen SD
Parkinsonism Relat Disord; 2012 Jun; 18(5):629-31. PubMed ID: 22342445
[TBL] [Abstract][Full Text] [Related]
3. Association between FGF20 rs12720208 gene polymorphism and Parkinson's disease: a meta-analysis.
Zhao X; Wu Y; Zhao C; Feng M
Neurol Sci; 2016 Jul; 37(7):1119-26. PubMed ID: 27023076
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 20 polymorphism in sporadic Parkinson's disease in Northern Han Chinese.
Xu X; Wang N; Xu H; Xie A; Jiang H; Xie J
J Clin Neurosci; 2013 Nov; 20(11):1588-90. PubMed ID: 23938014
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the rs12720208 single-nucleotide polymorphism of the FGF20 gene in Russian patients with sporadic Parkinson's disease].
Ustinova VV; Shadrina MI; Fedotova EIu; Illarioshkin SN; Limborskaia SA; Slominskiĭ PA
Genetika; 2012 Dec; 48(12):1437-9. PubMed ID: 23516905
[TBL] [Abstract][Full Text] [Related]
6. HLA-DRA is associated with Parkinson's disease in Iranian population.
Jamshidi J; Movafagh A; Emamalizadeh B; Zare Bidoki A; Manafi A; Ghasemi Firouzabadi S; Shahidi GA; Kazeminasab S; Petramfar P; Fazeli A; Motallebi M; Mortazavi-Tabatabaei SA; Kowsari A; Jafarian Z; Darvish H
Int J Immunogenet; 2014 Dec; 41(6):508-11. PubMed ID: 25319953
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of the effect of FGF20 rs1721100 and rs12720208 variant on the risk of sporadic Parkinson's disease: a meta-analysis.
Quan W; Li J; Liu L; Zhang Q; Qin Y; Pei X; Chen J
Neurol Sci; 2022 May; 43(5):3145-3152. PubMed ID: 34845561
[TBL] [Abstract][Full Text] [Related]
8. FGF20 rs12720208 SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients.
de Mena L; Cardo LF; Coto E; Miar A; Díaz M; Corao AI; Alonso B; Ribacoba R; Salvador C; Menéndez M; Morís G; Alvarez V
Neurosci Lett; 2010 Jul; 479(1):22-5. PubMed ID: 20471450
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of FGF 20 variants for susceptibility to Parkinson's disease in Eastern Indians.
Sadhukhan D; Das G; Biswas A; Ghosh S; Das SK; Ray K; Ray J
Neurosci Lett; 2018 May; 675():68-73. PubMed ID: 29604408
[TBL] [Abstract][Full Text] [Related]
10. SIPA1L2, MIR4697, GCH1 and VPS13C loci and risk of Parkinson's diseases in Iranian population: A case-control study.
Safaralizadeh T; Jamshidi J; Esmaili Shandiz E; Movafagh A; Fazeli A; Emamalizadeh B; Manafi N; Taghavi S; Tafakhori A; Darvish H
J Neurol Sci; 2016 Oct; 369():1-4. PubMed ID: 27653855
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 20 gene and Parkinson's disease in the Japanese population.
Satake W; Mizuta I; Suzuki S; Nakabayashi Y; Ito C; Watanabe M; Takeda A; Hasegawa K; Sakoda S; Yamamoto M; Hattori N; Murata M; Toda T
Neuroreport; 2007 Jun; 18(9):937-40. PubMed ID: 17515805
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 20 (FGF20) gene polymorphism and risk of Parkinson's disease: a meta-analysis.
Zhu R; Zhu Y; Liu X; He Z
Neurol Sci; 2014 Dec; 35(12):1889-94. PubMed ID: 24942208
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of the effect of FGF20 rs12720208 variant on the risk of Parkinson's disease: a meta-analysis.
Wang X; Sun X; Zhang X; Li H; Xie A
Neurol Res; 2017 Apr; 39(4):374-380. PubMed ID: 28191856
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of FGF20 in Chinese patients with Parkinson's disease.
Sun XY; Wang L; Cheng L; Li NN; Lu ZJ; Li JY; Peng R
Neurol Sci; 2017 May; 38(5):887-891. PubMed ID: 28238162
[TBL] [Abstract][Full Text] [Related]
15. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.
Wang G; van der Walt JM; Mayhew G; Li YJ; Züchner S; Scott WK; Martin ER; Vance JM
Am J Hum Genet; 2008 Feb; 82(2):283-9. PubMed ID: 18252210
[TBL] [Abstract][Full Text] [Related]
16. Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients.
Clarimon J; Xiromerisiou G; Eerola J; Gourbali V; Hellström O; Dardiotis E; Peuralinna T; Papadimitriou A; Hadjigeorgiou GM; Tienari PJ; Singleton AB
BMC Neurol; 2005 Jun; 5():11. PubMed ID: 15967032
[TBL] [Abstract][Full Text] [Related]
17. The analysis of association between SNCA, HUSEYO and CSMD1 gene variants and Parkinson's disease in Iranian population.
Shahmohammadibeni N; Rahimi-Aliabadi S; Jamshidi J; Emamalizadeh B; Shahmohammadibeni HA; Zare Bidoki A; Akhavan-Niaki H; Eftekhari H; Abdollahi S; Shekari Khaniani M; Shahmohammadibeni M; Fazeli A; Motallebi M; Taghavi S; Ahmadifard A; Shafiei Zarneh AE; Andarva M; Dadkhah T; Khademi E; Alehabib E; Rahimi M; Tafakhori A; Atakhorrami M; Darvish H
Neurol Sci; 2016 May; 37(5):731-6. PubMed ID: 26732583
[TBL] [Abstract][Full Text] [Related]
18. FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.
Wider C; Dachsel JC; Soto AI; Heckman MG; Diehl NN; Yue M; Lincoln S; Aasly JO; Haugarvoll K; Trojanowski JQ; Papapetropoulos S; Mash D; Rajput A; Rajput AH; Gibson JM; Lynch T; Dickson DW; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
Mov Disord; 2009 Feb; 24(3):455-9. PubMed ID: 19133659
[TBL] [Abstract][Full Text] [Related]
19. RAB7L1 promoter polymorphism and risk of Parkinson's disease; a case-control study.
Khaligh A; Goudarzian M; Moslem A; Mehrtash A; Jamshidi J; Darvish H; Emamalizadeh B
Neurol Res; 2017 May; 39(5):468-471. PubMed ID: 28245721
[TBL] [Abstract][Full Text] [Related]
20. Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease.
Guo Y; Le WD; Jankovic J; Yang HR; Xu HB; Xie WJ; Song Z; Deng H
Mov Disord; 2011 Aug; 26(9):1729-32. PubMed ID: 21469209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
